Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in Italy

Abstract

Overall, safety, effectiveness, and generalizability of sorafenib therapy in HCC was validated in field practice. The effectiveness of half-dosed sorafenib may have implications for tailored therapy.